Yes相关蛋白与结肠癌病理因素的相关性
Correlation of Yes-associated protein and the pathological factors of colon cancer

DOI: 10.6040/j.issn.1671-7554.0.2017.1216

Keywords: 转移灶,结肠癌,上皮-间质转化,原发灶,Yes相关蛋白,N-钙黏蛋白,
Epithelial-mesenchymal transition,Yes-associated protein,Colon cancer,N-cadherin,Metastasis,Primary tumor

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Harvey KF, Zhang X, Thomas DM, et al. The Hippo pathway and human cancer[J]. Nat Rev Cancer, 2013, 13(4): 246-257.
[2]	Zanconato F, Cordenonsi M, Piccolo S, et al. YAP/TAZ at the roots of cancer[J]. Cancer Cell, 2016, 29(6): 783-803.
[3]	Pefani DE, Pankova D, Abraham AG, et al. TGF-β targets the hippo pathway scaffold RASSF1A to facilitate YAP/SMAD2 nuclear translocation [J]. Mol Cell, 2016, 63(1): 156-166.
[4]	Pan D. Hippo signaling in organ size control[J]. Genes Dev, 2007, 21(8): 886-897.
[5]	Pan D. The hippo signaling pathway in development and cancer[J]. Dev Cell, 2010, 19(4): 491-505.
[6]	Maugeri-Saccà M, Barba M, Pizzuti L, et al. The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications[J]. Expert Rev Mol Med, 2015, 17: e14. doi: 10.1017/erm.2015.12.
[7]	Zhou Z, Zhu JS, Gao CP, et al. siRNA targeting YAP gene inhibits gastric carcinoma growth and tumor metastasis in SCID mice[J]. Oncol Lett, 2016, 11(4): 2806-2814.
[8]	Chaib I, Karachaliou N, Pilotto S, et al. Co-activation of STAT3 and YES-Associated Protein 1(YAP1)Pathway in EGFR-Mutant NSCLC[J]. J Natl Cancer Inst, 2017, 109(9). doi: 10.1093/jnci/djx014.
[9]	Zhang Y, Yuan J, Zhang X, et al. Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway [J]. Oncol Rep, 2016, 36(6): 3619-3626.
[10]	Wang L, Shi S, Guo Z, et al. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells[J]. PLoS One, 2013, 8(6): e65539. doi: 10.1371/journal.pone.0065539.
[11]	Vassilev A, Kaneko KJ, Shu H, et al. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm[J]. Genes Dev, 2001, 15(10): 1229-1241.
[12]	Scoazec JY. Epithelial-mesenchymal transition and colon cancer[J]. Ann Pathol, 2009, 29 Spec No 1:S63-64. doi: 10.1016/j.annpat.2009.07.037.
[13]	Nawa T, Kato J, Kawamoto H, et al. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology[J]. J Gastroenterol Hepatol, 2008, 23(3): 418-423.
[14]	刘传玲, 张晓东. 左右半结肠癌的差异及临床治疗理念[J]. 中国肿瘤临床, 2016, 43(18): 787-791. LIU Chuanling, ZHANG Xiaodong. Comparison and treatment of left- and right-side colon cancer [J]. Chinese Journal of Clinical Oncology, 2016, 43(18): 787-791.
[15]	Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[16]	Siegel R, Desantis C, Jemal A, et al. Colorectal cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64(2): 104-117.
[17]	Wang S, Li H, Wang G, et al. Yes-associated protein(YAP)expression is involved in epithelial-mesenchymal transition in hepatocellular carcinoma[J]. Clin Transl Oncol, 2016, 18(2): 172-177.
[18]	Lamouille S, Xu J, Derynck R, et al. Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014, 15(3): 178-196.
[19]	Zhang H, Liu CY, Zha ZY, et al. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition[J]. J Biol Chem, 2009, 284(20): 13355-13362.
[20]	Perumal N, Perumal M, Kannan A, et al. Morin impedes Yap nuclear translocation and fosters apoptosis through suppression of Wnt/β-catenin and NF-κB signaling in Mst1 overexpressed HepG2 cells [J]. Exp Cell Res, 2017, 355(2): 124-141.
[21]	Lee GH, Malietzis G, Askari A, et al. Is right-sided colon cancer different to left-sided colorectal cancer?-a systematic review[J]. Eur J Surg Oncol, 2015, 41(3): 300-308.
[22]	Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions [J]. J Clin Invest, 2009, 119(6): 1429-1437.
[23]	Iwatsuki M, Mimori K, Yokobori T, et al. Epithelial-mesenchymal transition in cancer development and its clinical significance[J]. Cancer Sci, 2010, 101(2): 293-299.
[24]	Shao DD, Xue W, Krall EB, et al. KRAS and YAP1 converge to regulate EMT and tumor survival [J]. Cell, 2014, 158(1): 171-184.
[25]	Cho SY, Kim K, Park MS, et al. Expression of Yes-associated protein 1 and its clinical significance in ovarian serous cystadenocarcinoma[J]. Oncol Rep, 2017, 37(5): 2620-2632.

Full-Text